INTRODUCTION: Breast cancer is the most common cancer and the leading cause of cancer death in women. Recent research indicates that human endogenous retroviruses (HERVs) may be linked to carcinogenesis, but the data remain controversial. METHODS: HERVs' expression was evaluated to show the differences between breast cancer and control samples, and their associations with clinicopathological parameters. Gene expression of 12 HERVs, i.e., ERVE-4, ERVW-1, ERVFRD-1, ERVV-1, ERV3-1, ERVH48-1, ERVMER34-1, ERVK-7, ERVK13-1, ERVK11-1, ERVK3-1, and HCP5, was analyzed by qPCR and/or TCGA datasets for breast cancer. RESULTS: ERV3-1, ERVFRD-1, ERVH48-1, and ERVW-1 provided data to support their tumor suppressor roles in breast cancer. ERV3-1 evinced the best performing diagnostic data based on qPCR, i.e. , AUC: 0.819 (p < 0.0001), sensitivity of 72.41%, and specificity of 89.66%. Lower levels of ERV3-1 were noted in advanced stage and higher grades, and significant negative association was found in relation to Ki-67 levels. Oncogenic roles may be inferred for ERVK13-1, ERVV-1, and ERVMER34-1. Data for ERVK-7, ERVE-4, ERVK11-1, and HCP5 remain inconclusive. CONCLUSION: Differential HERV expression may be applicable to evaluate novel biomarkers for breast cancer. However, more research is needed to reveal their real clinical impact, the biological roles, and regulatory mechanisms in breast carcinogenesis.

Department of Obstetrics and Gynecology Masaryk University and University Hospital Brno Brno Czechia

Department of Pathology Faculty of Medicine Masaryk University and University Hospital Brno Brno Czechia

Institute of Biology and Medical Genetics 1st Faculty of Medicine Charles University and General University Hospital Prague Prague Czechia

Institute of Pharmacology 1st Faculty of Medicine Charles University and General University Hospital Prague Prague Czechia

Zobrazit více v PubMed

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. . Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49. PubMed

Tadesse GF, Tegaw EM, Abdisa EK. Diagnostic performance of mammography and ultrasound in breast cancer: a systematic review and meta-analysis. J Ultrasound. 2023;26(2):355–67. PubMed PMC

Lother D, Robert M, Elwood E, Smith S, Tunariu N, Johnston SRD, et al. . Imaging in metastatic breast cancer, CT, PET/CT, MRI, WB-DWI, CCA: review and new perspectives. Cancer Imag. 2023;23(1):53. PubMed PMC

Najjar S, Allison KH. Updates on breast biomarkers. Virchows Arch. 2022;480(1):163–76. PubMed

Armstrong N, Ryder S, Forbes C, Ross J, Quek RGW. A systematic review of the international prevalence of BRCA mutation in breast cancer. Clin Epidemiol. 2019;11:543–61. PubMed PMC

Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discov. 2022;12(1):31–46. PubMed

Ouyang YF, Lu WX, Wang Y, Wang BT, Li FY, Li XH, et al. . Integrated analysis of mRNA and extrachromosomal circular DNA profiles to identify the potential mRNA biomarkers in breast cancer. Gene. 2023;857:147174. PubMed

Ortiz MMO, Andrechek ER. Molecular characterization and landscape of breast cancer models from a multi-omics perspective. J Mammary Gland Biol Neoplasia. 2023;28(1):12. PubMed PMC

Volovat SR, Volovat C, Hordila I, Hordila DA, Mirestean CC, Miron OT, et al. . MiRNA and LncRNA as potential biomarkers in triple-negative breast cancer: a review. Front Oncol. 2020;10:526850. PubMed PMC

Padroni L, De Marco L, Dansero L, Fiano V, Milani L, Vasapolli P, et al. . An epidemiological systematic review with meta-analysis on biomarker role of circulating MicroRNAs in breast cancer incidence. Int J Mol Sci. 2023;24(4):3910. PubMed PMC

Bannert N, Kurth R. Retroelements and the human genome: new perspectives on an old relation. Proc Natl Acad Sci U S A. 2004;101(Suppl 2):14572–9. PubMed PMC

Hohn O, Hanke K, Bannert N. HERV-K(HML-2), the best preserved family of HERVs: endogenization, expression, and implications in health and disease. Front Oncol. 2013;3:246. PubMed PMC

Grandi N, Tramontano E. Type W Human Endogenous Retrovirus (HERV-W) integrations and their mobilization by L1 machinery: contribution to the human transcriptome and impact on the host physiopathology. Viruses. 2017;9(7):162. PubMed PMC

Petrizzo A, Ragone C, Cavalluzzo B, Mauriello A, Manolio C, Tagliamonte M, et al. . Human endogenous retrovirus reactivation: implications for cancer immunotherapy. Cancers. 2021;13(9):1999. PubMed PMC

Stricker E, Peckham-Gregory EC, Scheurer ME. HERVs and cancer-A comprehensive review of the relationship of human endogenous retroviruses and human cancers. Biomedicines. 2023;11(3):936. PubMed PMC

Zapatka M, Borozan I, Brewer DS, Iskar M, Grundhoff A, Alawi M, et al. . The landscape of viral associations in human cancers. Nat Genet. 2020;52(3):320–30. PubMed PMC

Mulherkar TH, Gomez DJ, Sandel G, Jain P. Co-infection and cancer: host-pathogen interaction between dendritic cells and HIV-1, HTLV-1, and other oncogenic viruses. Viruses. 2022;14(9):2037. PubMed PMC

Kitsou K, Lagiou P, Magiorkinis G. Human endogenous retroviruses in cancer: oncogenesis mechanisms and clinical implications. J Med Virol. 2023;95(1):e28350. PubMed PMC

Johanning GL, Malouf GG, Zheng XF, Esteva FJ, Weinstein JN, Wang-Johanning F, et al. . Expression of human endogenous retrovirus-K is strongly associated with the basal-like breast cancer phenotype. Sci Rep. 2017;7:41960. PubMed PMC

Tavakolian S, Goudarzi H, Faghihloo E. Evaluating the expression level of HERV-K env, np9, rec and gag in breast tissue. Infect Agent Cancer. 2019;14(1):42. PubMed PMC

Tourang M, Fang L, Zhong Y, Suthar RS. Association between Human Endogenous Retrovirus K gene expression and breast cancer. Cell Mol Biomed Rep. 2021;1(1):7–13.

Curty G, Marston JL, de Mulder Rougvie M, Leal FE, Nixon DF, Soares MA. Human endogenous retrovirus K in cancer: a potential biomarker and immunotherapeutic target. Viruses. 2020;12(7):726. PubMed PMC

Xue B, Sechi LA, Kelvin DJ. Human endogenous retrovirus K (HML-2) in health and disease. Front Microbiol. 2020;11:1690. PubMed PMC

Vargiu L, Rodriguez-Tome P, Sperber GO, Cadeddu M, Grandi N, Blikstad V, et al. . Classification and characterization of human endogenous retroviruses; mosaic forms are common. Retrovirology. 2016;13:7. PubMed PMC

Kulski JK. Long noncoding RNA HCP5, a hybrid HLA class I endogenous retroviral gene: structure, expression, and disease associations. Cells. 2019;8(5):480. PubMed PMC

Wang LH, Luan T, Zhou SH, Lin J, Yang Y, Liu W, et al. . LncRNA HCP5 promotes triple negative breast cancer progression as a ceRNA to regulate BIRC3 by sponging miR-219a-5p. Cancer Med. 2019;8(9):4389–403. PubMed PMC

The Cancer Genome Atlas Program (TCGA). Available from: https://www.cancer.gov/tcga.

Goldman MJ, Craft B, Hastie M, Repecka K, McDade F, Kamath A, et al. . Visualizing and interpreting cancer genomics data via the Xena platform. Nat Biotechnol. 2020;38(6):675–8. PubMed PMC

Xena UCSC. Available From: https://xena.ucsc.edu/.

Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, et al. . Accurate normalization of realtime quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002;3(7):RESEARCH0034. PubMed PMC

Hellemans J, Mortier G, De Paepe A, Speleman F, Vandesompele J. qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol. 2007;8(2):R19. PubMed PMC

Wei YZ, Wei HL, Wei YF, Tan AH, Chen XY, Liao XQ, et al. . Screening and identification of human endogenous retrovirus-K mRNAs for breast cancer through integrative analysis of multiple datasets. Front Oncol. 2022;12:820883. PubMed PMC

Ko EJ, Song KS, Ock MS, Choi YH, Kim S, Kim HS, et al. . Expression profiles of human endogenous retrovirus (HERV)-K and HERV-R Env proteins in various cancers. BMB Rep. 2021;54(7):368–73. PubMed PMC

Kumar V, McClelland M, Nguyen J, De Robles G, Ittmann M, Castro P, et al. . Expression of endogenous retroviral RNA in prostate tumors has prognostic value and shows differences among Americans of african versus European/middle eastern ancestry. Cancers. 2021;13(24):6347. PubMed PMC

Roberts RM, Ezashi T, Schulz LC, Sugimoto J, Schust DJ, Khan T, et al. . Syncytins expressed in human placental trophoblast. Placenta. 2021;113:8–14. PubMed PMC

Wang QQ, Shi Y, Bian Q, Zhang NB, Wang M, Wang JN, et al. . Molecular mechanisms of syncytin-1 in tumors and placental development related diseases. Discov Oncol. 2023;14(1):104. PubMed PMC

Strissel PL, Ruebner M, Thiel F, Wachter D, Ekici AB, Wolf F, et al. . Reactivation of codogenic endogenous retroviral (ERV) envelope genes in human endometrial carcinoma and prestages: emergence of new molecular targets. Oncotarget. 2012;3(10):1204–19. PubMed PMC

Ficial M, Jegede OA, Sant’Angelo M, Hou Y, Flaifel A, Pignon JC, et al. . Expression of T-cell exhaustion molecules and human endogenous retroviruses as predictive biomarkers for response to nivolumab in metastatic clear cell renal cell carcinoma. Clin Cancer Res. 2021;27(5):1371–80. PubMed PMC

Gimenez J, Montgiraud C, Pichon JP, Bonnaud B, Arsac M, Ruel K, et al. . Custom human endogenous retroviruses dedicated microarray identifies self-induced HERV-W family elements reactivated in testicular cancer upon methylation control. Nucleic Acids Res. 2010;38(7):2229–46. PubMed PMC

Chen BS, Xu K, Zhang YM, Xu P, Li CM, Liu J, et al. . LncRNA ERVH48-1 contributes to the drug resistance of prostate cancer and proliferation through sponging of miR-4784 to the activation of the wnt/β-catenin pathway. Cancers. 2023;15(6):1902. PubMed PMC

Zhan X, Feng S, Zhou X, Liao W, Zhao B, Yang Q, et al. . Immunotherapy response and microenvironment provide biomarkers of immunotherapy options for patients with lung adenocarcinoma. Front Genet. 2022;13:1047435. PubMed PMC

Kasperek A, Beguin A, Bawa O, De Azevedo K, Job B, Massard C, et al. . Therapeutic potential of the human endogenous retroviral envelope protein HEMO: a pan-cancer analysis. Mol Oncol. 2022;16(7):1451–73. PubMed PMC

Li J, Gao CD, Liu C, Zhou C, Ma XR, Li HY, et al. . Four lncRNAs associated with breast cancer prognosis identified by coexpression network analysis. J Cell Physiol. 2019;234(8):14019–30. PubMed

Ghafouri-Fard S, Taherian-Esfahani Z, Dashti S, Kholghi Oskooei V, Taheri M, Samsami M. Gene expression of indoleamine and tryptophan dioxygenases and three long non-coding RNAs in breast cancer. Exp Mol Pathol. 2020;114:104415. PubMed

Wu JJ, Chen H, Ye MN, Wang B, Zhang YZ, Sheng JY, et al. . Long noncoding RNA HCP5 contributes to cisplatin resistance in human triple-negative breast cancer via regulation of PTEN expression. Biomed Pharmacother. 2019;115:108869. PubMed

Tong X, Yu ZL, Xing JN, Liu HZ, Zhou SH, Huang YE, et al. . LncRNA HCP5-encoded protein regulates ferroptosis to promote the progression of triple-negative breast cancer. Cancers. 2023;15(6):1880. PubMed PMC

Hu SP, Ge MX, Gao L, Jiang M, Hu KW. LncRNA HCP5 as a potential therapeutic target and prognostic biomarker for various cancers: a meta-analysis and bioinformatics analysis. Cancer Cell Int. 2021;21(1):686. PubMed PMC

Qin SY, Yang L, Kong S, Xu YH, Liang B, Ju SQ. LncRNA HCP5: a potential biomarker for diagnosing gastric cancer. Front Oncol. 2021;11:684531. PubMed PMC

Bai N, Ma Y, Zhao J, Li B. Knockdown of lncRNA HCP5 suppresses the progression of colorectal cancer by miR-299-3p/PFN1/AKT Axis. Cancer Manag Res. 2020;12:4747–58. PubMed PMC

The Overexpressed MicroRNAs miRs-182, 155, 493, 454, and U6 snRNA and Underexpressed let-7c, miR-328, and miR-451a as Potential Biomarkers in Invasive Breast Cancer and Their Clinicopathological Significance